Hepatocellular cancer ... that can be connected and point scientists to unused resources, as well as important questions to ask. TeCH will host a yearly conference where liver cancer researchers from ...

The FDA approved nivolumab and ipilimumab for unresectable or metastatic hepatocellular carcinoma ... The combination therapy was generally well-tolerated, but 18% of patients discontinued ...

Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given the increased risk of death from cirrhosis-related complications in patients ...